The pharmacogenetics of carboxylesterases: CES1 and CES2 genetic variants and their clinical effect.

Merali, Zahra

The pharmacogenetics of carboxylesterases: CES1 and CES2 genetic variants and their clinical effect. [electronic resource] - Drug metabolism and drug interactions 2014 - 143-51 p. digital

Publication Type: Journal Article; Review

2191-0162

10.1515/dmdi-2014-0009 doi


Angiotensin-Converting Enzyme Inhibitors--metabolism
Antiviral Agents--metabolism
Aspirin--metabolism
Benzimidazoles--metabolism
Camptothecin--analogs & derivatives
Carboxylesterase--genetics
Carboxylic Ester Hydrolases--chemistry
Central Nervous System Stimulants--metabolism
Clopidogrel
Dabigatran
Factor Xa Inhibitors--metabolism
Genotype
Humans
Imidazolidines--metabolism
Irinotecan
Isoenzymes--chemistry
Methylphenidate--metabolism
Oseltamivir--metabolism
Platelet Aggregation Inhibitors--metabolism
Polymorphism, Genetic
Pyridines--metabolism
Ticlopidine--analogs & derivatives